ETHZilla, formerly 180 Life Sciences, has secured a significant $156 million funding round through convertible notes to bolster its Ethereum holdings. This strategic move comes as the company aims to enhance its treasury strategy and expand into on-chain yield generation programs. Partnering with Electric Capital for this endeavor, ETHZilla plans to leverage its newly acquired capital for increased investment in Ethereum’s ecosystem. 180 Life Sciences previously secured $350 million through a PIPE (Private Investment in Public Equity) transaction last week, further solidifying their commitment to the Ethereum blockchain. With significant investments already made, ETHZilla is now positioning itself as a leading institutional player within the cryptocurrency sphere and a potential market mover. 82,186 ETH are currently held by the company, demonstrating its substantial involvement in the crypto landscape.